GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adlai Nortye Ltd (NAS:ANL) » Definitions » Other Stockholders Equity

ANL (Adlai Nortye) Other Stockholders Equity : $19.69 Mil (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Adlai Nortye Other Stockholders Equity?

Adlai Nortye's Other Stockholders Equity for the quarter that ended in Jun. 2024 was $19.69 Mil.

Adlai Nortye's quarterly Other Stockholders Equity increased from Jun. 2023 ($16.08 Mil) to Dec. 2023 ($18.02 Mil) and increased from Dec. 2023 ($18.02 Mil) to Jun. 2024 ($19.69 Mil).

Adlai Nortye's annual Other Stockholders Equity increased from Dec. 2021 ($7.61 Mil) to Dec. 2022 ($13.69 Mil) and increased from Dec. 2022 ($13.69 Mil) to Dec. 2023 ($18.02 Mil).

Adlai Nortye Other Stockholders Equity Historical Data

The historical data trend for Adlai Nortye's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adlai Nortye Other Stockholders Equity Chart

Adlai Nortye Annual Data
Trend Dec21 Dec22 Dec23
Other Stockholders Equity
7.61 13.69 18.02

Adlai Nortye Quarterly Data
Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Dec23 Jun24
Other Stockholders Equity Get a 7-Day Free Trial 13.69 14.82 16.08 18.02 19.69

Adlai Nortye Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Adlai Nortye Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Adlai Nortye's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Adlai Nortye Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adlai Nortye Ltd (NAS:ANL) » Definitions » Other Stockholders Equity
Comparable Companies
ADVM IGMS NTRB ABOS CUE VERU INO ZIVO INZY ACET VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
685 US Highway 1, New Jersey Biotechnology Development Center, 2nd floor, North Brunswick, NJ, USA, 08902
Website
https://www.adlainortye.com
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.